![]() Viapath Viapath provides pathology and testing its partners, and NHS and private sector organizations. | ![]() EKF Diagnostics EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate. | ![]() NanoString NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics. | Yingsheng Biology Yingsheng Biology (简称英盛) is a company specializing in researching, producing and selling in vitro diagnostic reagents and medical equipment, and providing third-party medical testing services. | ||
Founding Date | Founding Date 2009 | Founding Date 1990 | Founding Date 2003 | Founding Date 2009 | Founding Date 2009 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Bedford, GB HQ London, GB London, GB London, GB London, GB Orpington, GB | Locations Penarth, GB HQ Shanghai, CN Barleben, DE Leipzig, DE Boerne, US Elkhart, US | Locations Seattle, US HQ Amsterdam, NL | Locations HQ | Locations Chennai, IN HQ Bhubaneswar, IN |
Employees | Employees 2701% decrease | Employees 303 | Employees 7038% decrease | Employees N/A | Employees 90 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 157.5 m | Valuation ($) 5.1 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) £122m (FY, 2018) | Revenue (est.) £51.6m (FY, 2025) | Revenue (est.) $127.3m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods £88.9m (FY, 2018) | Cost of goods £19.7m (FY, 2025) | Cost of goods $65.5m (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit £33.1m (FY, 2018) | Gross profit £32.1m (FY, 2025) | Gross profit $61.8m (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income £2.5m (FY, 2018) | Net income £2.5m (FY, 2025) | Net income ($159.5m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 152m | Total funding raised $ 14.5m | Total funding raised N/A |

EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate.
View company
NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics.
View companyYingsheng Biology (简称英盛) is a company specializing in researching, producing and selling in vitro diagnostic reagents and medical equipment, and providing third-party medical testing services.
View companyTechmed Healthcare operates as a chain of hospitals.
View company